{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T18:39:21Z","timestamp":1774463961132,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1124\/jpet.112.198770","type":"journal-article","created":{"date-parts":[[2012,9,15]],"date-time":"2012-09-15T10:41:58Z","timestamp":1347705718000},"page":"712-724","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Identification and Functional Characterization of a Novel UDP-Glucuronosyltransferase 2A1 Splice Variant: Potential Importance in Tobacco-Related Cancer Susceptibility"],"prefix":"10.1016","volume":"343","author":[{"given":"Ryan T.","family":"Bushey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.112.198770_bib1","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1124\/dmd.109.030569","article-title":"UDP-glucuronosyltransferase 1A10: activity against the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, and a potential role for a novel UGT1A10 promoter deletion polymorphism in cancer susceptibility","volume":"38","author":"Balliet","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.112.198770_bib2","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1158\/0008-5472.CAN-08-4143","article-title":"Characterization of UGTs active against SAHA and association between SAHA glucuronidation activity phenotype with UGT genotype","volume":"69","author":"Balliet","year":"2009","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.112.198770_bib3","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1074\/jbc.M109.083139","article-title":"Modulation of the human glucuronosyltransferase UGT1A pathway by splice isoform polypeptides is mediated through protein-protein interactions","volume":"285","author":"Bellemare","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.112.198770_bib4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/FPC.0b013e328341db05","article-title":"Characterization of UDP-glucuronosyltransferase 2A1 (UGT2A1) variants and their potential role in tobacco carcinogenesis","volume":"21","author":"Bushey","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/jpet.112.198770_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/FPC.0b013e3282f4dbdd","article-title":"Identification of a prevalent functional missense polymorphism in the UGT2B10 gene and its association with UGT2B10 inactivation against tobacco-specific nitrosamines","volume":"18","author":"Chen","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/jpet.112.198770_bib6","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1124\/mol.108.045500","article-title":"Novel polymorphic human UDP-glucuronosyltransferase 2A3: cloning, functional characterization of enzyme variants, comparative tissue expression, and gene induction","volume":"74","author":"Court","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.112.198770_bib7","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1093\/carcin\/bgm164","article-title":"N-OH-PhIP by UDP-glucuronosyltransferase 1A10","volume":"28","author":"Dellinger","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1124\/jpet.112.198770_bib8","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1124\/dmd.105.009100","article-title":"Importance of UDP-glucuronosyltransferase 1A10 (UGT1A10) in the detoxification of polycyclic aromatic hydrocarbons: decreased glucuronidative activity of the UGT1A10139Lys isoform","volume":"34","author":"Dellinger","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.112.198770_bib9","first-page":"1978","article-title":"Characterization of benzo(a)pyrene-trans-7,8-dihydrodiol glucuronidation by human tissue microsomes and overexpressed UDP-glucuronosyltransferase enzymes","volume":"62","author":"Fang","year":"2002","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.112.198770_bib10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2174\/138920008783331158","article-title":"The UDP-glucuronosyltransferases as oligomeric enzymes","volume":"9","author":"Finel","year":"2008","journal-title":"Curr Drug Metab"},{"key":"10.1124\/jpet.112.198770_bib11","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1124\/dmd.107.016402","article-title":"Interactions between human UGT1A1, UGT1A4, and UGT1A6 affect their enzymatic activities","volume":"35","author":"Fujiwara","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.112.198770_bib12","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1158\/1055-9965.EPI-06-0823","article-title":"The UDP-glucuronosyltransferase 2B17 gene deletion polymorphism: sex-specific association with urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol glucuronidation phenotype and risk for lung cancer","volume":"16","author":"Gallagher","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1124\/jpet.112.198770_bib13","doi-asserted-by":"crossref","first-page":"42108","DOI":"10.1074\/jbc.M106742200","article-title":"Homodimerization of human bilirubin-uridine-diphosphoglucuronate glucuronosyltransferase-1 (UGT1A1) and its functional implications","volume":"276","author":"Ghosh","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.112.198770_bib14","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/FPC.0b013e3282f1f118","article-title":"Genetic diversity at the UGT1 locus is amplified by a novel 3\u2032 alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activity","volume":"17","author":"Girard","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/jpet.112.198770_bib15","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nature02168","article-title":"The International HapMap Project","volume":"426","year":"2003","journal-title":"Nature"},{"key":"10.1124\/jpet.112.198770_bib16","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1124\/dmd.108.022731","article-title":"The configuration of the 17-hydroxy group variably influences the glucuronidation of \u03b2-estradiol and epiestradiol by human UDP-glucuronosyltransferases","volume":"36","author":"It\u00e4aho","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.112.198770_bib17","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1042\/bj3400837","article-title":"Cloning and characterization of a novel human olfactory UDP-glucuronosyltransferase","volume":"340","author":"Jedlitschky","year":"1999","journal-title":"Biochem J"},{"key":"10.1124\/jpet.112.198770_bib18","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1093\/carcin\/14.12.2637","article-title":"The glucuronidation of hydroxylated metabolites of benzo[a]pyrene and 2-acetylaminofluorene by cDNA-expressed human UDP-glucuronosyltransferases","volume":"14","author":"Jin","year":"1993","journal-title":"Carcinogenesis"},{"key":"10.1124\/jpet.112.198770_bib19","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1124\/jpet.112.192658","article-title":"Quantification of hepatic UGT1A splice variant expression and correlation of UGT1A1 variant expression with glucuronidation activity","volume":"342","author":"Jones","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.198770_bib20","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/hmg\/5.5.645","article-title":"Crigler-Najjar syndrome type II is inherited both as a dominant and as a recessive trait","volume":"5","author":"Koiwai","year":"1996","journal-title":"Hum Mol Genet"},{"key":"10.1124\/jpet.112.198770_bib21","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1124\/mol.109.063289","article-title":"A molecular model of the human UDP-glucuronosyltransferase 1A1, its membrane orientation, and the interactions between different parts of the enzyme","volume":"77","author":"Laakkonen","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.112.198770_bib22","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/35057062","article-title":"Initial sequencing and analysis of the human genome","volume":"409","author":"Lander","year":"2001","journal-title":"Nature"},{"key":"10.1124\/jpet.112.198770_bib23","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/01.fpc.0000175596.52443.ef","article-title":"Genotype-phenotype correlation between the polymorphic UGT2B17 gene deletion and NNAL glucuronidation activities in human liver microsomes","volume":"15","author":"Lazarus","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/jpet.112.198770_bib24","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/hep.21464","article-title":"Regulation of the UGT1A1 bilirubin-conjugating pathway: role of a new splicing event at the UGT1A locus","volume":"45","author":"L\u00e9vesque","year":"2007","journal-title":"Hepatology"},{"key":"10.1124\/jpet.112.198770_bib25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/FPC.0b013e328336ef1c","article-title":"Extensive splicing of transcripts encoding the bile acid-conjugating enzyme UGT2B4 modulates glucuronidation","volume":"20","author":"L\u00e9vesque","year":"2010","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/jpet.112.198770_bib26","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/01.fpc.0000173483.13689.56","article-title":"Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily","volume":"15","author":"Mackenzie","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/jpet.112.198770_bib27","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/FPC.0b013e3283498147","article-title":"Transcriptional diversity at the UGT2B7 locus is dictated by extensive pre-mRNA splicing mechanisms that give rise to multiple mRNA splice variants","volume":"21","author":"M\u00e9nard","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/jpet.112.198770_bib28","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jmb.2007.03.066","article-title":"Crystal structure of the cofactor-binding domain of the human phase II drug-metabolism enzyme UDP-glucuronosyltransferase 2B7","volume":"369","author":"Miley","year":"2007","journal-title":"J Mol Biol"},{"key":"10.1124\/jpet.112.198770_bib29","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/sj.onc.1209375","article-title":"Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer","volume":"25","author":"Nagar","year":"2006","journal-title":"Oncogene"},{"key":"10.1124\/jpet.112.198770_bib30","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2133\/dmpk.21.357","article-title":"Tissue-specific mRNA expression profiles of human phase I metabolizing enzymes except for cytochrome P450 and phase II metabolizing enzymes","volume":"21","author":"Nishimura","year":"2006","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/jpet.112.198770_bib31","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1124\/dmd.108.024596","article-title":"Functional characterization of low-prevalence missense polymorphisms in the UDP-glucuronosyltransferase 1A9 gene","volume":"37","author":"Olson","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.112.198770_bib32","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1074\/jbc.M609417200","article-title":"Oligomerization of the UDP-glucuronosyltransferase 1A proteins: homo- and heterodimerization analysis by fluorescence resonance energy transfer and co-immunoprecipitation","volume":"282","author":"Opera\u00f1a","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.112.198770_bib33","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0090-9556(24)15084-2","article-title":"O-glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by human UDP-glucuronosyltransferases 2B7 and 1A9","volume":"28","author":"Ren","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.112.198770_bib34","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/FPC.0b013e3283330767","article-title":"Human UDP-glucuronosyltransferase UGT2A2: cDNA construction, expression, and functional characterization in comparison with UGT2A1 and UGT2A3","volume":"19","author":"Sneitz","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/jpet.112.198770_bib35","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1124\/dmd.108.024844","article-title":"UDP-glucuronosyltransferases (UGTs) 2B7 and UGT2B17 display converse specificity in testosterone and epitestosterone glucuronidation, whereas UGT2A1 conjugates both androgens similarly","volume":"37","author":"Sten","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.112.198770_bib36","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1186\/bcr1539","article-title":"Characterization of tamoxifen and 4-hydroxytamoxifen glucuronidation by human UGT1A4 variants","volume":"8","author":"Sun","year":"2006","journal-title":"Breast Cancer Res"},{"key":"10.1124\/jpet.112.198770_bib37","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1124\/dmd.107.017145","article-title":"Glucuronidation of active tamoxifen metabolites by the human UDP glucuronosyltransferases","volume":"35","author":"Sun","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.112.198770_bib38","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1124\/dmd.31.5.670","article-title":"Glucuronidation activity of the UGT2B17 enzyme toward xenobiotics","volume":"31","author":"Turgeon","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.112.198770_bib39","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1124\/dmd.32.4.413","article-title":"Human udp-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid","volume":"32","author":"Uchaipichat","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.112.198770_bib40","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nature07509","article-title":"Alternative isoform regulation in human tissue transcriptomes","volume":"456","author":"Wang","year":"2008","journal-title":"Nature"},{"key":"10.1124\/jpet.112.198770_bib41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1124\/dmd.104.001321","article-title":"Analysis of substrate specificities and tissue expression of rat UDP-glucuronosyltransferases UGT1A7 and UGT1A8","volume":"33","author":"Webb","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.112.198770_bib42","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1124\/dmd.32.3.281","article-title":"Glucuronidation and the UDP-glucuronosyltransferases in health and disease","volume":"32","author":"Wells","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.112.198770_bib43","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1124\/dmd.32.1.72","article-title":"Characterization of N-glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human liver: importance of UDP-glucuronosyltransferase 1A4","volume":"32","author":"Wiener","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.112.198770_bib44","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1158\/0008-5472.CAN-03-3219","article-title":"Correlation between UDP-glucuronosyltransferase genotypes and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone glucuronidation phenotype in human liver microsomes","volume":"64","author":"Wiener","year":"2004","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.112.198770_bib45","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1124\/dmd.30.4.397","article-title":"Glucuronidation: an important mechanism for detoxification of benzo[a]pyrene metabolites in aerodigestive tract tissues","volume":"30","author":"Zheng","year":"2002","journal-title":"Drug Metab Dispos"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524184443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524184443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.112.198770","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:16:26Z","timestamp":1739985386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524184443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0022356524184443"],"URL":"https:\/\/doi.org\/10.1124\/jpet.112.198770","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification and Functional Characterization of a Novel UDP-Glucuronosyltransferase 2A1 Splice Variant: Potential Importance in Tobacco-Related Cancer Susceptibility","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.112.198770","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}